Diabetes Technol Ther

• 

  Publication Venue For

  • Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney Diseases..  22:546-552. 2020
  • Rationale and Design for a GRADE Substudy of Continuous Glucose Monitoring..  21:682-690. 2019
  • Automated Insulin Delivery Systems: Hopes and Expectations of Family Members..  20:222-228. 2018
  • Diabetes Technology and the Human Factor..  20:S128-S138. 2018
  • Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting..  19:391-399. 2017
  • Web-Based Management Trial of Diabetes Care..  18:605-606. 2016
  • Diabetes and Partners..  18:278-279. 2016
  • Future artificial pancreas technology for type 1 diabetes: what do users want?.  17:311-315. 2015
  • Psychosocial assessment of artificial pancreas (AP): commentary and review of existing measures and their applicability in AP research..  17:295-300. 2015
  • Technological advancement in the treatment of diabetes-ignoring psychosocial impact at our peril..  17:149-151. 2015
  • Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trial..  16:310-316. 2014
  • Social networking and understanding alcohol-associated risk for people with type 1 diabetes: friend or foe?.  15:308-314. 2013
  • Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience..  13:601-606. 2011